Studies on the mechanism of energy metabolism via AMPK/PGC-1α signaling pathway induced by compatibility of Ligusticum chuanxiong Hort and Gastrodia

• Published in: Phytotherapy research Vol. 38; no. 10; pp. 4835 - 4854
• Main Authors: Ni, Ni, Yang, Lu-Ping, Lin, Xiao, Hong, Yan-Long, Shen, Lan
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.10.2024
• Subjects: AMP-activated protein kinase; Biological activity; Biological properties; Biological samples; Blood; Body weight; Calcium ions; Compatibility; Cyclic AMP; Cytokines; Energy consumption; Energy intake; Energy metabolism; Enzyme-linked immunosorbent assay; Food intake; Headache; Kinases; Liver; Magnesium; Metabolism; Metabolites; Migraine; Na+/K+-exchanging ATPase; Neostriatum; Oxaloacetic acid; Protein turnover; Signal transduction; Thirst; Water intake; Water intakes; AMPK/PGC-1α signaling pathway; Gastrodia; mechanism; Ligusticum chuanxiong Hort; energy metabolism
• ISSN: 0951-418X; 1099-1573; 1099-1573
• DOI: 10.1002/ptr.7623

AMP-activated protein kinase (AMPK) regulates overall energy consumption and energy intake through cytokines. Ligusticum striatum DC (CX) combined with Gastrodia elata Blume (TM) has been used for migraine treatment for millennia. When used alone in clinical practice, CX causes symptoms of thirst, irritability, and yellow urine and has influenced the levels of cytokines such as AMP that activate the AMPK pathway of energy metabolism. However, relationships between this compatibility prescription, integral biological energy metabolism, and the AMPK pathway remain unclear. Studies were performed by treating normal rats with physiological saline, CX extract, CX coupled TM extract, and TM extracts separately for 4 weeks. Food intake, water intake, urine output, stool output, and body weight were monitored once a week by the metabolic cage method. Values of FBG, BUN, TP, TC and TG in blood samples were detected approaching the whole blood automatic detector from 1 to 4 weeks. Na -K -ATPase, Ca -Mg -ATPase, cAMP, and cGMP activity were determined by the enzyme-linked immunosorbent assay (ELISA); the biological samples that were obtained at 1, 2, 3, and 4 weeks after drug administration were tested by GC-TOF-MS. Then real-time PCR and Western Blot were applied to detect changes in expression of some substances involved in energy metabolism. The results demonstrated that administering CX alone increased energy input, mobility, and respiratory exchange ratio, accelerated energy consumption, and caused inflammatory infiltration in the liver. CX coupled with TM led to lower energy metabolism and liver damage in comparison with CX used alone. Moreover, CX-treated rats harbored higher levels of differential metabolites (including pyrophosphate, oxaloacetic acid, and galactinol). Glycerophospholipid metabolism and the citrate cycle are closely related to the differential metabolites above. In addition, CX-induced unbalanced energy metabolism depends on cAMP activation mediated by the AMPK/PGC-1α pathway in rats. Our findings suggest that CX-induced energy metabolism imbalance was corrected after coupling with TM by mediating the AMPK/PGC-1α pathway.